Functional characterization of the lectin pathway of complement in human serum

Molecular Immunology

Volumn 39, Issue 11, 2003, Pages 655-668

  Roos, Anja ^a   Bouwman, Lee H ^a   Munoz, Jeric ^a   Zuiverloon, Tahlita ^a   Faber Krol, Maria C ^a   Fallaux van den Houten, Francien C ^a   Klar Mohamad, Ngaisah ^a   Hack, C Erik ^b   Tilanus, Marcel G ^c   Daha, Mohamed R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Alternative pathway; C1q; Classical pathway; Complement; Lectin pathway; MBL

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT MEMBRANE ATTACK COMPLEX; IMMUNOGLOBULIN A; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LECTIN; MANNAN; MANNAN BINDING LECTIN; MONOCLONAL ANTIBODY; OLIGONUCLEOTIDE; POLYCLONAL ANTIBODY;

ADULT; ANALYTIC METHOD; ARTICLE; COMPLEMENT ACTIVATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; GENE FUNCTION; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SERUM;

ANTIBODIES; COMPLEMENT C1Q; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT SYSTEM PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MANNANS; MANNOSE-BINDING LECTIN; MUTATION;

EID: 18744371008     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(02)00254-7     Document Type: Article

References (42)

1. Collard C.D., Väkevä A., Morrissey M.A., Agah A., Rollins S.A., Reenstra W.R., Buras J.A., Meri S., Stahl G.L. Complement activation after oxidative stress: role of the lectin complement pathway. Am. J. Pathol. 156:2000;1549-1556.
2. Conrad K., Schmechta H., Klafki A., Lobeck G., Uhlig H.H., Gerdi S., Henker J. Serological differentiation of inflammatory bowel diseases. Eur. J. Gastroenterol. Hepatol. 14:2002;129-135.
3. Crawford K., Alper C.A. Genetics of the complement system. Rev. Immunogenet. 2:2000;323-338.
4. Fredrikson G.N., Truedsson L., Sjoholm A.G. New procedure for the detection of complement deficiency by ELISA. Analysis of activation pathways and circumvention of rheumatoid factor influence. J. Immunol. Methods. 166:1993;263-270.
5. Galili U. The alpha-gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation. Biochimie. 83:2001;557-563.
6. Garred, P., Madsen, H.O., Svejgaard, A., 1996. Genetics of human mannan-binding protein. In: Ezekowitz, R.A.B., Sastry, K.N., Reid, K.B.M. (Eds.), Collectins and Innate Immunity. Springer, Heidelberg, pp. 139-164.
7. Garred P., Madsen H.O., Halberg P., Petersen J., Kronborg G., Svejgaard A., Andersen V., Jacobsen S. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum. 42:1999a;2145-2152.
8. Garred P., Pressler T., Madsen H.O., Frederiksen B., Svejgaard A., Hoiby N., Schwartz M., Koch C. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J. Clin. Invest. 104:1999;431-437.
9. Graudal N.A., Madsen H.O., Tarp U., Svejgaard A., Jurik G., Graudal H.K., Garred P. The association of variant mannose-binding lectin genotypes with radiographic outcome in rheumatoid arthritis. Arthritis Rheum. 43:2000;515-521.
10. Gulati S., Sastry K., Jensenius J.C., Rice P.A., Ram S. Regulation of the mannan-binding lectin pathway of complement on Neisseria gonorrhoeae by C1-inhibitor and alpha 2-macroglobulin. J. Immunol. 168:2002;4078-4086.
11. Hibberd M.L., Sumiya M., Booy R., Levin M. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Lancet. 353:1999;1049-1053.
12. Hoekzema R., Martens M., Brouwer M.C., Hack C.E. The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the "arms" of C1q. Mol. Immunol. 25:1988;485-494.
13. Laich A., Sim R.B. Complement C4bC2 complex formation: an investigation by surface plasmon resonance. Biochim. Biophys. Acta. 1544:2001;96-112.
14. Lipscombe R.J., Sumiya M., Hill A.V., Lau Y.L., Levinsky R.J., Summerfield J.A., Turner M.W. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum. Mol. Genet. 1:1992;709-715.
15. Madsen H.O., Garred P., Kurtzhals J.A.L., Lamm L.U., Ryder L.P., Thiel S., Svejgaard A. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics. 40:1994;37-44.
16. Matsushita M., Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J. Exp. Med. 176:1992;1497-1502.
17. Matsushita M., Endo Y., Fujita T. Complement-activating complex of ficolin and mannose-binding lectin-associated serine protease. J. Immunol. 164:2000a;2281-2284.
18. Matsushita M., Thiel S., Jensenius J.C., Terai I., Fujita T. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J. Immunol. 165:2000;2637-2642.
19. Matsushita M., Kuraya M., Hamasaki N., Tsujimura M., Shiraki H., Fujita T. Activation of the lectin complement pathway by H-ficolin (Hakata antigen). J. Immunol. 168:2002;3502-3506.
20. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acids Res. 16:1988;1215.
21. Neonato M.G., Lu C.Y., Guilloud-Bataille M., Lapouméroulie C., Nabeel-Jassim H., Dabit D., Girot R., Krishnamoorthy R., Feingold J., Besmond C., Elion J. Genetic polymorphism of the mannose-binding protein gene in children with sickle cell disease: identification of three new variant alleles and relationship to infections. Eur. J. Hum. Genet. 7:1999;679-686.
22. Neth O., Hann I., Turner M.W., Klein N.J. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet. 358:2001;614-618.
23. Petersen S.V., Thiel S., Jensen L., Vorup-Jensen T., Koch C., Jensenius J.C. Control of the classical and the MBL pathway of complement activation. Mol. Immunol. 37:2000;803-811.
24. Petersen S.V., Thiel S., Jensen L., Steffensen R., Jensenius J.C. An assay for the mannan-binding lectin pathway of complement activation. J. Immunol. Methods. 257:2001a;107-116.
25. Petersen S.V., Thiel S., Jensenius J.C. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol. Immunol. 38:2001;133-149.
26. Peterslund N.A., Koch C., Jensenius J.C., Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet. 358:2001;637-638.
27. Quinton J.F., Sendid B., Reumaux D., Duthilleul P., Cortot A., Grandbastien B., Charrier G., Targan S.R., Colombel J.F., Poulain D. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 42:1998;788-791.
28. Roos A., Bouwman L.H., van Gijlswijk-Janssen D.J., Faber-Krol M.C., Stahl G.L., Daha M.R. Human IgA activates the complement system via the mannan-binding lectin pathway. J. Immunol. 167:2001a;2861-2868.
29. Roos A., Nauta A.J., Broers D., Faber-Krol M.C., Trouw L.A., Drijfhout J.W., Dah M.R. Specific inhibition of the classical complement pathway by C1q-binding peptides. J. Immunol. 167:2001;7052-7059.
30. Suankratay C., Zhang X.H., Zhang Y., Lint T.F., Gewurz H. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway. J. Immunol. 160:1998;3006-3013.
31. Sumiya M., Super M., Tabona P., Levinsky R.J., Arai T., Turner M.W., Summerfield J.A. Molecular basis of opsonic defect in immunodeficient children. Lancet. 337:1991;1569-1570.
32. Summerfield J.A., Ryder S., Sumiya M., Thursz M., Gorchein A., Monteil M.A., Turner M.W. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet. 345:1995;886-889.
33. Super M., Levinsky R.J., Turner M.W. The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations. Clin. Exp. Immunol. 79:1990;144-150.
34. Super M., Gillies S.D., Foley S., Sastry K., Schweinle J.E., Silverman V.J., Ezekowitz R.A.B. Distinct and overlapping functions of allelic forms of human mannose binding protein. Nat. Genet. 2:1992;50-55.
35. Thiel S., Vorup-Jensen T., Stover C.M., Schwaeble W., Laursen S.B., Poulsen K., Willis A.C., Eggleton P., Hansen S., Holmskov U., Reid K.B.M., Jensenius J.C. A second serine protease associated with mannan-binding lectin that activates complement. Nature. 386:1997;506-510.
36. Trouw L.A., Roos A., Daha M.R. Autoantibodies to complement components. Mol. Immunol. 38:2001;199-206.
37. Wallis R. Dominant effects of mutations in the collagenous domain of mannose-binding protein. J. Immunol. 168:2002;4553-4558.
38. Wallis R., Cheng J.Y. Molecular defects in variant forms of mannose-binding protein associated with immunodeficiency. J. Immunol. 163:1999;4953-4959.
39. Walport M.J. Complement. Part I. N. Engl. J. Med. 344:2001a;1058-1066.
40. Walport M.J. Complement. Part II. N. Engl. J. Med. 344:2001;1140-1144.
41. Zhang M.X., Lupan D.M., Kozel T.R. Mannan-specific immunoglobulin G antibodies in normal human serum mediate classical pathway initiation of C3 binding to Candida albicans. Infect. Immun. 65:1997;3822-3827.
42. Zimmermann-Nielsen E., Baatrup G., Thorlacius-Ussing O., Agnholt J., Svehag S.E. Complement activation mediated by mannan-binding lectin in plasma from healthy individuals and from patients with SLE, Crohn's disease and colorectal cancer. Suppressed activation by SLE plasma. Scand. J. Immunol. 55:2002;105-110.